JUAN MARÍA DE LA
OBRA SIERRA
Forscher in der Zeit 1988-2015
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario Marqués de Valdecilla (37)
2024
-
Oculomotor Dysfunction in Idiopathic and LRRK2-Parkinson's Disease and At-Risk Individuals
Journal of Parkinson's disease, Vol. 14, Núm. 4, pp. 797-808
2023
-
Analysis of retinal nerve layers in idiopathic, LRRK2-associated Parkinson's disease and unaffected carriers of G2019S mutation
Parkinsonism and Related Disorders, Vol. 106
-
Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™
Neurologia, Vol. 38, Núm. 5, pp. 326-333
-
Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease
npj Parkinson's Disease, Vol. 9, Núm. 1
2022
-
Sensor-based gait analysis in the premotor stage of LRRK2 G2019S-associated Parkinson's disease
Parkinsonism and Related Disorders, Vol. 98, pp. 21-26
2021
-
Biomonitoring and bioaccessibility of environmental airborne manganese in relation to motor function in a healthy adult population
NeuroToxicology, Vol. 87, pp. 195-207
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications, Vol. 12, Núm. 1
-
Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage
Nature Communications, Vol. 12, Núm. 1
-
Serial DaT-SPECT imaging in asymptomatic carriers of LRRK2 G2019S mutation: 8 years’ follow-up
European Journal of Neurology, Vol. 28, Núm. 12, pp. 4204-4208
2020
-
Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information
Nature Communications, Vol. 11, Núm. 1
2019
-
Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
npj Parkinson's Disease, Vol. 5, Núm. 1
-
Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability
npj Parkinson's Disease, Vol. 5, Núm. 1
-
SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344
-
The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight
Movement Disorders, Vol. 34, Núm. 12, pp. 1851-1863
2018
-
MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy
Movement Disorders, Vol. 33, Núm. 4, pp. 600-608
-
α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain
Movement Disorders, Vol. 33, Núm. 4, pp. 637-641
2017
-
Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-Associated Parkinson disease
Neurology, Vol. 89, Núm. 5, pp. 439-444
2016
-
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression
BMC Neurology, Vol. 16, Núm. 1
-
Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson's disease
Neurobiology of Aging, Vol. 38, pp. 214.e1-214.e5
-
Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum
Neuropathology and Applied Neurobiology, Vol. 42, Núm. 5, pp. 451-462